CenterStar Asset Management’s Eli Lilly LLY Stock Holding History

CenterStar Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-500	Closed	-$291K	–	328
2023 Q4	$291K	Hold	500	–	–	0.04%	254
2023 Q3	$269K	Buy	+500	New	+$258K	0.06%	272
2023 Q1	–	Hold	0	–	-$264	–	255
2022 Q4	–	Hold	0	–	–	–	152
2022 Q3	–	Hold	0	–	-$112K	–	434
2022 Q2	–	Hold	0	–	–	–	317
2022 Q1	–	Hold	0	–	–	–	111
2021 Q4	–	Hold	0	–	-$594K	–	764
2021 Q3	–	Hold	0	–	–	–	334
2021 Q2	–	Hold	0	–	-$4.4M	–	594
2021 Q1	–	Hold	0	–	–	–	46
2020 Q4	–	Hold	0	–	–	–	146
2020 Q3	–	Hold	0	–	-$93K	–	682
2020 Q2	–	Hold	0	–	–	–	551
2020 Q1	–	Hold	0	–	–	–	102
2019 Q4	–	Hold	0	–	–	–	72
2019 Q1	–	Hold	0	–	-$6K	–	478
2018 Q4	–	Hold	0	–	–	–	377
2018 Q3	–	Hold	0	–	–	–	316
2018 Q2	–	Hold	0	–	–	–	622
2018 Q1	–	Hold	0	–	–	–	968
2017 Q4	–	Hold	0	–	–	–	336

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

CenterStar Asset Management's LLY Position: Q1 2024 in Review

CenterStar Asset Management sold out of Eli Lilly (LLY) in Q1 2024, closing a stake of 1,401 shares — an estimated $818K sold.

CenterStar Asset Management first reported a position in LLY in Q2 2023 and held it in 3 quarters. The position peaked at $997K in Q2 2023. 3,460 funds tracked by Wall St. Rank hold LLY as of Q1 2024.

CenterStar Asset Management reported no remaining Eli Lilly position as of Q1 2024 after selling out during the quarter.
CenterStar Asset Management sold 1,401 Eli Lilly shares in Q1 2024, an estimated $818K.
CenterStar Asset Management first reported a position in Eli Lilly in Q2 2023 and held it in 3 quarters.
CenterStar Asset Management's Eli Lilly position peaked at $997K in Q2 2023.
3,460 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2024.

Based on CenterStar Asset Management's 13F filing for Q1 2024, filed 18 Apr 2024.